| abstract |
The present invention describes a method of treating cancer in a subject where the cancer is selected from the group consisting of colon cancer, rectal cancer, pancreatic cancer, liver cancer, oral cancer, uterine cancer, mucous-like liposarcoma, bile duct carcinoma, limb sarcoma, retroperitoneal sarcoma and pleomorphic fibrosarcoma, and where the subject has previously undergone at least one unsuccessful cancer chemotherapy program, which includes the introduction of coenzyme Q10 (CoQ10) intravenously at a dose of at least 5 mg / kg per dose, in which CoQ10 administered at least once a week, at least twice a week or at least three times a week. The invention provides successful treatment of cancer in a population of patients who are particularly difficult to treat. |